Dr. Julie Schwarz, M.D., Ph.D.
Claim this profileWashington University School of Medicine
Studies Cervical Cancer
Studies Pancreatic Cancer
7 reported clinical trials
12 drugs studied
Area of expertise
1Cervical Cancer
Stage IV
Stage III
Stage II
2Pancreatic Cancer
Stage III
Affiliated Hospitals
Clinical Trials Julie Schwarz, M.D., Ph.D. is currently running
Pelvic Exam Tool
for Gynecologic Cancer Survivors
The two goals of this study are to establish a standardized method of assessing the pelvic floor for patients undergoing pelvic radiation and to determine the feasibility of inverse-RT planning using MRI to identify dosimetric constraints of the pelvic floor musculature for use in radiation planning. The investigators hypothesize that an exam-based diagnostic tool will provide more information about the areas of injury related to pelvic radiation than patient-reported outcomes, and could be used in future studies of preventive strategies. An exam-based tool will also allow measurement of the pain dose-response to radiation treatment of specific areas, which could be excluded from radiation fields during treatment planning.
Recruiting1 award N/A
Defactinib + Radiotherapy
for Pancreatic Cancer
Patients with advanced pancreas adenocarcinoma will be randomized on a 6:1 basis to receive standard of care chemotherapy followed by adaptive stereotactic body radiotherapy (SBRT) with concurrent and adjuvant FAK inhibitor defactinib (experimental arm) or standard of care chemotherapy followed by SBRT (control arm). Patients enrolled to the experimental arm will be assessed for clinical outcomes such as progression free survival (PFS), local control, distant control, and toxicity. The first 6 patients randomized to the experimental arm will be considered the safety lead-in and will be assessed for dose-limiting toxicities (DLTs). The 6 patients randomized to the control arm will be evaluated for correlatives but will not be included in the analysis for primary and secondary endpoints.
Recruiting1 award Phase 219 criteria
More about Julie Schwarz, M.D., Ph.D.
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Julie Schwarz, M.D., Ph.D. has experience with
- Cisplatin
- Radiation Treatment
- Telaglenastat
- Defactinib
- Stereotactic Body Radiotherapy
- Intensity Modulated Radiation Therapy
Breakdown of trials Julie Schwarz, M.D., Ph.D. has run
Cervical Cancer
Pancreatic Cancer
Endometrial Cancer
Stomach Cancer
Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Julie Schwarz, M.D., Ph.D. specialize in?
Julie Schwarz, M.D., Ph.D. focuses on Cervical Cancer and Pancreatic Cancer. In particular, much of their work with Cervical Cancer has involved Stage IV patients, or patients who are Stage III.
Is Julie Schwarz, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Julie Schwarz, M.D., Ph.D. is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Julie Schwarz, M.D., Ph.D. has studied deeply?
Yes, Julie Schwarz, M.D., Ph.D. has studied treatments such as Cisplatin, Radiation treatment, Telaglenastat.
What is the best way to schedule an appointment with Julie Schwarz, M.D., Ph.D.?
Apply for one of the trials that Julie Schwarz, M.D., Ph.D. is conducting.
What is the office address of Julie Schwarz, M.D., Ph.D.?
The office of Julie Schwarz, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.